Your browser doesn't support javascript.
loading
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients.
Brito-Zerón, Pilar; Melchor, Sheila; Seror, Raphaèle; Priori, Roberta; Solans, Roser; Kostov, Belchin; Baldini, Chiara; Carubbi, Francesco; Callejas, Jose Luis; Guisado-Vasco, Pablo; Hernández-Molina, Gabriela; Pasoto, Sandra G; Valim, Valeria; Sisó-Almirall, Antoni; Mariette, Xavier; Carreira, Patricia; Ramos-Casals, Manuel.
Afiliación
  • Brito-Zerón P; Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Barcelona, Spain.
  • Melchor S; Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona, Spain.
  • Seror R; Servicio de Reumatologia, Hospital Universitario, 12 de Octubre, Madrid, Spain.
  • Priori R; Department of Rheumatology, National Reference Center for Sjögren Syndrome and Rare Autoimmune Diseases, Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, AP-HP, Le Kremlin Bicêtre, France.
  • Solans R; Department of Internal Medicine and Medical Specialties, Rheumatology Clinic, Sapienza University of Rome, Rome, Italy.
  • Kostov B; Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona, Spain.
  • Baldini C; Primary Care Centre Les Corts, Consorci d'Atenció Primària de Salut Barcelona Esquerra (CAPSBE), Barcelona, Spain.
  • Carubbi F; Primary healthcare transversal research group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Callejas JL; Department of Statistics and Operations Research, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain.
  • Guisado-Vasco P; Rheumatology Unit, University of Pisa, Pisa, Italy.
  • Hernández-Molina G; COVID-19 Medical Unit, San Salvatore Hospital, Department of Medicine, ASL1 Avezzano-Sulmona-L'Aquila, L'Aquila, Italy.
  • Pasoto SG; Department of Internal Medicine, Hospital San Cecilio, Granada, Spain.
  • Valim V; Department of Internal Medicine, Hospital Universitario Quironsalud, Madrid, Spain.
  • Sisó-Almirall A; Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico.
  • Mariette X; Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Carreira P; Department of Medicine, Federal University of Espírito Santo, Vitória, Brazil.
  • Ramos-Casals M; Primary Care Centre Les Corts, Consorci d'Atenció Primària de Salut Barcelona Esquerra (CAPSBE), Barcelona, Spain.
Rheumatology (Oxford) ; 60(6): 2946-2957, 2021 06 18.
Article en En | MEDLINE | ID: mdl-33316070
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Sjögren / SARS-CoV-2 / COVID-19 / Hospitalización Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome de Sjögren / SARS-CoV-2 / COVID-19 / Hospitalización Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: España